Eloxx Pharmaceuticals, Inc. - ELOX

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q3 2023 · Q2 2023
Value (USD)
Total reported value ($000)
$1.902M
QoQ value delta ($000)
+$1.428M (+301.27%)
Implied price effect (QoQ)
+24.34%
Shares
Total shares
396,755
QoQ shares delta
+273,815 (+222.72%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (ELOX)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q3 2023)

Top 25 only Full list
Early Q4 2023 data: only 2 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
ARMISTICE CAPITAL, LLC 1,322 275,000 0.02%
MENORA MIVTACHIM HOLDINGS LTD. 251 52,355 0.0%
Altshuler Shaham Ltd 120 25,123 0.0%
VANGUARD GROUP INC 99 20,786 0.0%
GEODE CAPITAL MANAGEMENT, LLC 93 19,588 0.0%
Tower Research Capital LLC (TRC) 8 1,830 0.0%
WELLS FARGO & COMPANY/MN 5 1,172 0.0%
ROYAL BANK OF CANADA 3 526 0.0%
UBS Group AG 1 291 0.0%
JPMORGAN CHASE & CO 0 1 0.0%
MORGAN STANLEY 0 79 0.0%
GROUP ONE TRADING, L.P. 0 4 0.0%